EUVIMEDScopri EUVIMED
Übersichtsarbeit

Phytochemicals in regulating PD ‐1/ PD‐L1 and immune checkpoint blockade therapy

Qi Zhang iD, Chenying Yang, Xingsu Gao, Ju Dong, Caiyun Zhong iD

Phytotherapy Research · 2024

DOI: 10.1002/ptr.8082 ↗

At a glance

Übersichtsarbeit in Phytotherapy Research, 2024. Written by Qi Zhang and 4 co-authors. Institution: Department of Public Health, School of Medicine & Holistic Integrative Medicine, Nanjing University of Chinese Medicine, Nanjing, China. Major MEDLINE topics: B7-H1 Antigen, Neoplasms. Cited 29 times so far (Crossref); 141 references. Funded by: Jiangsu Province "The 14th Five-year Plan" Key Discipline-Public Health and Preventive Medicine.

AbstractSubjectsDati bibliograficiCiteRelated studies

Abstract (original language)

Clinical treatment and preclinical studies have highlighted the role of immune checkpoint blockade in cancer treatment. Research has been devoted to developing immune checkpoint inhibitors in combination with other drugs to achieve better efficacy or reduce adverse effects. Phytochemicals sourced from vegetables and fruits have demonstrated antiproliferative, proapoptotic, anti‐migratory, and antiangiogenic effects against several cancers. Phytochemicals also modulate the tumor microenvironment such as T cells, regulatory T cells, and cytokines. Recently, several phytochemicals have been reported to modulate immune checkpoint proteins in in vivo or in vitro models. Phytochemicals decreased programmed cell death ligand‐1 expression and synergized programmed cell death receptor 1 (PD‐1) monoclonal antibody to suppress tumor growth. Combined administration of phytochemicals and PD‐1 monoclonal antibody enhanced the tumor growth inhibition as well as CD4 + /CD8 + T‐cell infiltration. In this review, we discuss immune checkpoint molecules as potential therapeutic targets of cancers. We further assess the impact of phytochemicals including carotenoids, polyphenols, saponins, and organosulfur compounds on cancer PD‐1/programmed cell death ligand‐1 immune checkpoint molecules and document their combination effects with immune checkpoint inhibitors on various malignancies.

Subjects

MeSH terms (MEDLINE)

B7-H1 AntigenNeoplasmsHumansImmune Checkpoint InhibitorsProgrammed Cell Death 1 ReceptorImmune Checkpoint ProteinsLigandsImmunotherapyAntibodies, MonoclonalTumor Microenvironment

Author keywords

PD-1/PD-L1cancer immunotherapyimmune checkpointphytochemical

Substances

B7-H1 AntigenImmune Checkpoint InhibitorsProgrammed Cell Death 1 ReceptorImmune Checkpoint ProteinsLigandsAntibodies, Monoclonal

Authors and institutions

  • Department of Public Health, School of Medicine & Holistic Integrative Medicine, Nanjing University of Chinese Medicine, Nanjing, China.
  • Yinzhou Center for Disease Control and Prevention, Ningbo, China.
  • Department of Nutrition and Food Safety, School of Public Health, Nanjing Medical University, Nanjing, China.

ORCID profiles: Qi Zhang, Caiyun Zhong

Funding

  • Jiangsu Province "The 14th Five-year Plan" Key Discipline-Public Health and Preventive Medicine

Cite

APA

Zhang, Q., Yang, C., Gao, X., Dong, J., & Zhong, C. (2024). Phytochemicals in regulating PD ‐1/ PD‐L1 and immune checkpoint blockade therapy. Phytotherapy Research. https://doi.org/10.1002/ptr.8082

Vancouver

Zhang Q, Yang C, Gao X, Dong J, Zhong C. Phytochemicals in regulating PD ‐1/ PD‐L1 and immune checkpoint blockade therapy. Phytotherapy Research. 2024. doi:10.1002/ptr.8082

BibTeX
@article{Zhang2024,
  author = {Zhang, Qi and Yang, Chenying and Gao, Xingsu and Dong, Ju and Zhong, Caiyun},
  title = {Phytochemicals in regulating PD ‐1/ PD‐L1 and immune checkpoint blockade therapy},
  journal = {Phytotherapy Research},
  year = {2024},
  doi = {10.1002/ptr.8082}
}
Start for free →